CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 30 filers reported holding CATALYST BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,290 | +37.2% | 66,951 | 0.0% | 0.01% | +71.4% |
| Q2 2023 | $23,540 | +69.9% | 66,951 | 0.0% | 0.01% | +40.0% |
| Q1 2023 | $13,859 | +39497.1% | 66,951 | 0.0% | 0.01% | -50.0% |
| Q4 2022 | $35 | -99.9% | 66,951 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $34,000 | -71.4% | 66,951 | 0.0% | 0.01% | -66.7% |
| Q2 2022 | $119,000 | +170.5% | 66,951 | 0.0% | 0.03% | +275.0% |
| Q1 2022 | $44,000 | -27.9% | 66,951 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $61,000 | -77.8% | 66,951 | 0.0% | 0.01% | -70.8% |
| Q3 2021 | $275,000 | – | 66,951 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 202,281 | $2,759,000 | 1.56% |
| ACUTA CAPITAL PARTNERS, LLC | 450,000 | $6,138,000 | 1.16% |
| NEXTHERA CAPITAL LP | 311,175 | $4,244,000 | 0.78% |
| Avoro Capital Advisors LLC | 400,000 | $5,456,000 | 0.35% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $818,000 | 0.34% |
| B. Riley Wealth Advisors, Inc. | 62,500 | $853,000 | 0.12% |
| Kalos Management, Inc. | 12,100 | $222,000 | 0.10% |
| J. Goldman & Co LP | 124,500 | $1,698,000 | 0.09% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $205,000 | 0.02% |
| DRW Securities, LLC | 12,000 | $164,000 | 0.02% |